
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10390303
[patent_doc_number] => 20150275309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/438594
[patent_app_country] => US
[patent_app_date] => 2013-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 29856
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438594
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/438594 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | Oct 29, 2013 | Abandoned |
Array
(
[id] => 9330135
[patent_doc_number] => 20140056917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death'
[patent_app_type] => utility
[patent_app_number] => 14/059782
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30006
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059782
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059782 | FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death | Oct 21, 2013 | Abandoned |
Array
(
[id] => 10468991
[patent_doc_number] => 20150354007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'SIALYLTRANSFERASE ST3GAL6 AS A MARKER FOR MULTIPLE MYELOMA'
[patent_app_type] => utility
[patent_app_number] => 14/435001
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7775
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435001
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435001 | SIALYLTRANSFERASE ST3GAL6 AS A MARKER FOR MULTIPLE MYELOMA | Oct 14, 2013 | Abandoned |
Array
(
[id] => 9491695
[patent_doc_number] => 20140142101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'CORRELATION OF MOLECULAR MARKERS WITH CLINICAL OUTCOME IN GBM PATIENTS RADIATION TREATED WITH OR WITHOUT GEFITINIB'
[patent_app_type] => utility
[patent_app_number] => 14/053321
[patent_app_country] => US
[patent_app_date] => 2013-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8126
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053321
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053321 | CORRELATION OF MOLECULAR MARKERS WITH CLINICAL OUTCOME IN GBM PATIENTS RADIATION TREATED WITH OR WITHOUT GEFITINIB | Oct 13, 2013 | Abandoned |
Array
(
[id] => 10477478
[patent_doc_number] => 20150362495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF PROSTATE CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 14/435128
[patent_app_country] => US
[patent_app_date] => 2013-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35751
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435128 | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis | Oct 8, 2013 | Issued |
Array
(
[id] => 9339547
[patent_doc_number] => 20140066329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'LUNG CANCER DIAGNOSTIC ASSAY'
[patent_app_type] => utility
[patent_app_number] => 14/046271
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15694
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046271
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046271 | LUNG CANCER DIAGNOSTIC ASSAY | Oct 3, 2013 | Abandoned |
Array
(
[id] => 10506324
[patent_doc_number] => 09234191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Cytotoxic ribonuclease variants'
[patent_app_type] => utility
[patent_app_number] => 14/046671
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13931
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046671
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046671 | Cytotoxic ribonuclease variants | Oct 3, 2013 | Issued |
Array
(
[id] => 9596678
[patent_doc_number] => 20140193358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/045958
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25612
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045958
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045958 | TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS | Oct 3, 2013 | Abandoned |
Array
(
[id] => 9330099
[patent_doc_number] => 20140056881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'METHOD AND KIT FOR THE DETECTION OF GENES ASSOCIATED WITH PIK3CA MUTATION AND INVOLVED IN PI3K/AKT PATHWAY ACTIVATION IN THE ER-POSTITIVE AND HER2-POSITIVE SUBTYPES WITH CLINICAL IMPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/032984
[patent_app_country] => US
[patent_app_date] => 2013-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14344
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14032984
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/032984 | METHOD AND KIT FOR THE DETECTION OF GENES ASSOCIATED WITH PIK3CA MUTATION AND INVOLVED IN PI3K/AKT PATHWAY ACTIVATION IN THE ER-POSTITIVE AND HER2-POSITIVE SUBTYPES WITH CLINICAL IMPLICATIONS | Sep 19, 2013 | Abandoned |
Array
(
[id] => 10282100
[patent_doc_number] => 20150167097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'CLASSIFIERS OF NF-kB PATHWAY ACTIVATION, DEVICES, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/414507
[patent_app_country] => US
[patent_app_date] => 2013-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12593
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414507 | CLASSIFIERS OF NF-kB PATHWAY ACTIVATION, DEVICES, AND METHODS OF USE THEREOF | Sep 19, 2013 | Abandoned |
Array
(
[id] => 10369395
[patent_doc_number] => 20150254400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'GROUPING FOR CLASSIFYING GASTRIC CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/429283
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 752
[patent_figures_cnt] => 752
[patent_no_of_words] => 15051
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429283
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429283 | GROUPING FOR CLASSIFYING GASTRIC CANCER | Sep 17, 2013 | Abandoned |
Array
(
[id] => 11685960
[patent_doc_number] => 09684001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Biomarkers for head-and-neck cancers and precancers'
[patent_app_type] => utility
[patent_app_number] => 14/028287
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 40
[patent_no_of_words] => 58779
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028287
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028287 | Biomarkers for head-and-neck cancers and precancers | Sep 15, 2013 | Issued |
Array
(
[id] => 9262136
[patent_doc_number] => 20130344065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Combination Treatment with VEGF-C Antagonists'
[patent_app_type] => utility
[patent_app_number] => 14/013203
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 31266
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013203
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/013203 | Combination Treatment with VEGF-C Antagonists | Aug 28, 2013 | Abandoned |
Array
(
[id] => 9262558
[patent_doc_number] => 20130344487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'METHOD TO DETECT PROSTATE CANCER IN A SAMPLE'
[patent_app_type] => utility
[patent_app_number] => 14/011988
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16745
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011988
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/011988 | METHOD TO DETECT PROSTATE CANCER IN A SAMPLE | Aug 27, 2013 | Abandoned |
Array
(
[id] => 9192124
[patent_doc_number] => 20130331439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'Methods for Diagnosing Stomach Cancer Using MicroRNAs'
[patent_app_type] => utility
[patent_app_number] => 13/970016
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31667
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970016
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/970016 | Methods for Diagnosing Stomach Cancer Using MicroRNAs | Aug 18, 2013 | Abandoned |
Array
(
[id] => 10333634
[patent_doc_number] => 20150218638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'METHODS FOR ASSESSMENT OF PEPTIDE-SPECIFIC IMMUNITY'
[patent_app_type] => utility
[patent_app_number] => 14/425284
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10865
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425284
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/425284 | METHODS FOR ASSESSMENT OF PEPTIDE-SPECIFIC IMMUNITY | Aug 18, 2013 | Abandoned |
| 13/964570 | Methods for Diagnosing Pancreatic Cancer Using MicroRNAs | Aug 11, 2013 | Abandoned |
Array
(
[id] => 9495996
[patent_doc_number] => 08734804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Treatment of myelosuppression'
[patent_app_type] => utility
[patent_app_number] => 13/963526
[patent_app_country] => US
[patent_app_date] => 2013-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 29229
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13963526
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/963526 | Treatment of myelosuppression | Aug 8, 2013 | Issued |
Array
(
[id] => 15054889
[patent_doc_number] => 10457733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Agents that modulate immune cell activation and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 14/418548
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 13
[patent_no_of_words] => 47419
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418548
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/418548 | Agents that modulate immune cell activation and methods of use thereof | Aug 1, 2013 | Issued |
Array
(
[id] => 9537612
[patent_doc_number] => 20140162254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'BREAST TUMOUR GRADING'
[patent_app_type] => utility
[patent_app_number] => 13/954050
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 50027
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13954050
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/954050 | BREAST TUMOUR GRADING | Jul 29, 2013 | Abandoned |